Share on StockTwits

Select Medical Holdings (NYSE:SEM) Director Thomas Scully unloaded 12,686 shares of the stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $14.06, for a total transaction of $178,365.16. Following the transaction, the director now directly owns 143,389 shares of the company’s stock, valued at approximately $2,016,049. The sale was disclosed in a filing with the SEC, which is available at this link.

Select Medical Holdings (NYSE:SEM) remained flat at $14.02 during during mid-day trading trading on Friday. 539,012 shares of the company’s stock traded hands. Select Medical Holdings has a one year low of $7.91 and a one year high of $16.17. The stock’s 50-day moving average is $14.87 and its 200-day moving average is $13.86. The company has a market cap of $1.823 billion and a price-to-earnings ratio of 15.95.

Select Medical Holdings (NYSE:SEM) last posted its quarterly earnings results on Thursday, August 7th. The company reported $0.27 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.27. The company had revenue of $772.80 million for the quarter, compared to the consensus estimate of $777.16 million. During the same quarter in the prior year, the company posted $0.27 earnings per share. The company’s quarterly revenue was up 2.1% on a year-over-year basis. On average, analysts predict that Select Medical Holdings will post $0.94 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which is scheduled for Friday, August 29th. Stockholders of record on Wednesday, August 20th will be given a dividend of $0.10 per share. This represents a $0.40 dividend on an annualized basis and a yield of 2.85%. The ex-dividend date of this dividend is Monday, August 18th.

Select Medical Holdings Corporation is an operator of both specialty hospitals and outpatient rehabilitation clinics in the United States.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.